Profile data is unavailable for this security.
About the company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is a China-based company mainly engaged in research and development, manufacturing and marketing of biomedicine. The Company's products include aminolevulinic acid hydrochloride topical powder (trade name: ALA) and hemporfin or injection (trade name: FuMeiDa), and doxorubicin hydrochloride liposome injection (trade name: LIBOd), among others. Its products are mainly used for skin venereal disease treatment and anti-tumor treatment. The Company conducts its businesses in the domestic market.
- Revenue in CNY (TTM)691.62m
- Net income in CNY105.20m
- Incorporated1996
- Employees948.00
- LocationShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co LtdZhangjiang Hi-tech ParkNo.308 Cailun RoadPudong District, Zhangjiang Hi-tech ParkSHANGHAI 201210ChinaCHN
- Phone+86 2 158553583
- Fax+86 2 158553893
- Websitehttp://www.fd-zj.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cisen Pharmaceutical Co Ltd | 4.25bn | 529.01m | 6.45bn | 3.40k | 12.18 | 1.11 | -- | 1.52 | 1.17 | 1.17 | 9.41 | 12.89 | 0.585 | 2.15 | 6.06 | 1,250,659.00 | 7.33 | 6.94 | 9.10 | 8.56 | 57.72 | 56.27 | 12.53 | 10.77 | 2.63 | -- | 0.0329 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Jianmin Pharmaceutical Group Co Ltd | 3.98bn | 427.95m | 6.70bn | 2.50k | 15.61 | 2.80 | -- | 1.68 | 2.80 | 2.80 | 25.98 | 15.61 | 0.9793 | 6.99 | 4.16 | 1,592,652.00 | 10.62 | 10.87 | 18.49 | 19.11 | 42.34 | 43.04 | 10.84 | 9.32 | 1.38 | -- | 0.1492 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
| Sichuan Huiyu Pharmaceutical Co Ltd | 1.12bn | 278.20m | 6.82bn | 1.36k | 24.52 | 1.76 | -- | 6.09 | 0.6567 | 0.6567 | 2.64 | 9.16 | 0.2335 | 1.18 | 21.25 | 820,954.90 | 5.66 | 10.41 | 7.08 | 12.76 | 83.40 | 89.89 | 24.23 | 21.42 | 2.57 | -- | 0.1488 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 691.62m | 105.20m | 6.90bn | 948.00 | 85.74 | 3.77 | -- | 9.97 | 0.0998 | 0.0998 | 0.6509 | 2.27 | 0.2482 | 1.53 | 1.50 | 729,558.10 | 3.76 | 7.03 | 4.43 | 9.05 | 90.24 | 92.17 | 15.15 | 17.26 | 6.06 | -- | 0.0048 | 26.31 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| Wuhan Keqian Biology Co Ltd | 902.14m | 299.11m | 6.92bn | 923.00 | 23.19 | 1.79 | -- | 7.67 | 0.6404 | 0.6404 | 1.93 | 8.28 | 0.1968 | 2.44 | 2.47 | 977,402.10 | 6.51 | 13.29 | 7.62 | 15.49 | 63.87 | 76.49 | 33.08 | 45.71 | 4.71 | -- | 0.0209 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.99bn | 236.52m | 6.93bn | 3.65k | 29.31 | 1.70 | -- | 1.74 | 0.2327 | 0.2327 | 3.92 | 4.02 | 0.4694 | 0.7941 | 7.74 | 1,091,879.00 | 3.23 | 0.6992 | 5.93 | 5.12 | 48.73 | 20.23 | 6.87 | 3.45 | 2.96 | -- | 0.0896 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 835.23m | 257.55m | 7.00bn | 1.17k | 27.10 | 3.05 | -- | 8.38 | 0.3111 | 0.3111 | 1.01 | 2.76 | 0.2788 | 1.09 | 2.84 | 711,439.10 | 8.60 | 9.38 | 11.35 | 12.84 | 54.34 | 53.09 | 30.84 | 27.14 | 2.00 | -- | 0.156 | 23.53 | 6.83 | 27.35 | 7.87 | 42.07 | 24.32 | 50.48 |
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.38bn | -37.82m | 7.00bn | 1.05k | -- | 3.90 | -- | 2.94 | -0.055 | -0.055 | 3.34 | 2.52 | 0.5684 | 17.73 | 2.04 | 2,270,402.00 | -0.8772 | -2.92 | -1.79 | -5.30 | 28.07 | 28.14 | -1.54 | -5.77 | 1.46 | 0.5127 | 0.4841 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| China Animal Husbandry Industry Co., Ltd | 5.43bn | 87.90m | 7.02bn | 4.33k | 79.82 | 1.28 | -- | 1.29 | 0.0861 | 0.0861 | 5.31 | 5.37 | 0.6127 | 4.56 | 3.76 | 1,254,216.00 | 0.7085 | 6.23 | 1.00 | 9.01 | 16.42 | 24.29 | 1.16 | 8.69 | 1.54 | -- | 0.1909 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
Data as of Nov 05 2024. Currency figures normalised to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 261.41k | 0.04% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 128.82k | 0.02% |
| Tebon Fund Management Co. Ltd.as of 30 Jun 2024 | 77.70k | 0.01% |
| Dimensional Fund Advisors Ltd.as of 31 Jul 2024 | 39.44k | 0.01% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 752.00 | 0.00% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2024 | 649.00 | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
| CCB Principal Asset Management Co., Ltd.as of 29 Feb 2024 | 0.00 | 0.00% |
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2024 | 0.00 | 0.00% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
